Related references
Note: Only part of the references are listed.Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review
Carlo Alviggi et al.
FERTILITY AND STERILITY (2018)
Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis
Carlo Alviggi et al.
HUMAN REPRODUCTION UPDATE (2018)
Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial
Yangying Xu et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2018)
Persistent organic pollutants (POPs) in human follicular fluid and in vitro fertilization outcomes, a pilot study
Michael S. Bloom et al.
REPRODUCTIVE TOXICOLOGY (2017)
The Distribution of stroma and antral Follicles Differs between insulin-Resistance and hyperandrogenism-Related Polycystic Ovarian syndrome
Carlo Alviggi et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH plus Luteinizing Hormone, Human Menopausal Gonadotropin or FSH plus Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the Personalized Medicine Era: A Meta-analysis
Daniele Santi et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Individualization of treatment in controlled ovarian stimulation: myth or reality?
Alessandro Conforti et al.
BIOCHIMICA CLINICA (2017)
Antioxidants for female subfertility
Marian G. Showell et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept
Carlo Alviggi et al.
FERTILITY AND STERILITY (2016)
Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Panagiotis Drakopoulos et al.
HUMAN REPRODUCTION (2016)
In Estimated Good Prognosis Patients Could Unexpected Hyporesponse to Controlled Ovarian Stimulation be Related to Genetic Polymorphisms of FSH Receptor?
Carlo Alviggi et al.
REPRODUCTIVE SCIENCES (2016)
The effect of FT500 Plus® on ovarian stimulation in PCOS women
Carlo Alviggi et al.
REPRODUCTIVE TOXICOLOGY (2016)
Impact of gene polymorphisms of gonadotropins and their receptors on human reproductive success
Livio Casarini et al.
REPRODUCTION (2015)
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice
Antonio La Marca et al.
HUMAN REPRODUCTION UPDATE (2014)
FSHR polymorphism p.N680S mediates different responses to FSH in vitro
Livio Casarini et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Association between intrafollicular concentration of benzene and outcome of controlled ovarian stimulation in IVF/ICSI cycles: a pilot study
Carlo Alviggi et al.
JOURNAL OF OVARIAN RESEARCH (2014)
The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age
A. La Marca et al.
HUMAN REPRODUCTION (2013)
A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology
Carlo Alviggi et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2013)
Elevated blood plasma antioxidant status is favourable for achieving IVF/ICSI pregnancy
Agne Velthut et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2013)
Association of Hexachlorobenzene (HCB), Dichlorodiphenyltrichloroethane (DDT), and Dichlorodiphenyldichloroethylene (DDE) with in Vitro Fertilization (IVF) Outcomes
Shruthi Mahalingaiah et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2012)
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer
Paul Devroey et al.
FERTILITY AND STERILITY (2012)
Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome
V. Gallot et al.
HUMAN REPRODUCTION (2012)
Frequent polymorphisms of FSH receptor do not influence antral follicle responsiveness to follicle-stimulating hormone administration as assessed by the Follicular Output RaTe (FORT)
Vanessa Krebs Genro et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2012)
Serum anti-Mullerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation
V. K. Genro et al.
HUMAN REPRODUCTION (2011)
Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles
Sesh Kamal Sunkara et al.
HUMAN REPRODUCTION (2011)
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
A. P. Ferraretti et al.
HUMAN REPRODUCTION (2011)
Follicle-Stimulating Hormone Receptor Polymorphism (G-29A) Is Associated with Altered Level of Receptor Expression in Granulosa Cells
Swapna S. Desai et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF
Valentina Biasoni et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2011)
Who needs LH in ovarian stimulation?
C. Alviggi et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2011)
Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism
C. Alviggi et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2011)
Single-nucleotide polymorphisms in the FSH receptor gene and ovarian performance: Future role in IVF
Lamiya Mohiyiddeen et al.
HUMAN FERTILITY (2010)
Approaches to improve the diagnosis and management of infertility
P. Devroey et al.
HUMAN REPRODUCTION UPDATE (2009)
Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism
Swati K. Achrekar et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2009)
Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures
Giovanni Ruvolo et al.
FERTILITY AND STERILITY (2007)
Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial
Anders Nyboe Andersen et al.
HUMAN REPRODUCTION (2006)
Exploiting LH in ovarian stimulation
C Alviggi et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2006)
Oxidative stress and its implications in female infertility - a clinician's perspective
A Agarwal et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2005)
Genetic complexity of FSH receptor function
J Gromoll et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2005)
A common single nucleotide polymorphism in Exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle
RR Greb et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH:: a pharmacogenetic approach to controlled ovarian hyperstimulation
HM Behre et al.
PHARMACOGENETICS AND GENOMICS (2005)
Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial
G De Placido et al.
HUMAN REPRODUCTION (2005)
Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques
AP Ferraretti et al.
FERTILITY AND STERILITY (2004)
Role of reactive oxygen species in the pathophysiology of human reproduction
A Agarwal et al.
FERTILITY AND STERILITY (2003)
Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH
G De Placido et al.
HUMAN REPRODUCTION (2001)
Share Paper
